Switch theme
Sign up to access all valuation multiples
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
2019
73
LTM Revenue $7.6M
LTM EBITDA -$91.8M
$187M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Taysha GTx has a last 12-month revenue of $7.6M and a last 12-month EBITDA of -$91.8M.
In the most recent fiscal year, Taysha GTx achieved revenue of $8.3M and an EBITDA of -$88.0M.
Taysha GTx expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Taysha GTx valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $15.5M | $8.3M | XXX | XXX | XXX |
| Gross Profit | n/a | n/a | XXX | XXX | XXX |
| Gross Margin | NaN% | NaN% | XXX | XXX | XXX |
| EBITDA | -$105M | -$88.0M | XXX | XXX | XXX |
| EBITDA Margin | -681% | -1055% | XXX | XXX | XXX |
| Net Profit | -$166M | -$112M | XXX | XXX | XXX |
| Net Margin | -1074% | -1339% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Taysha GTx's stock price is $1.
Taysha GTx has current market cap of $262M, and EV of $187M.
See Taysha GTx trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $187M | $262M | XXX | XXX | XXX | XXX | $-0.36 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Taysha GTx has market cap of $262M and EV of $187M.
Taysha GTx's trades at 24.4x LTM EV/Revenue multiple, and -2.0x LTM EBITDA.
Analysts estimate Taysha GTx's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Taysha GTx and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $187M | XXX | XXX | XXX |
| EV/Revenue | 22.4x | XXX | XXX | XXX |
| EV/EBITDA | -2.1x | XXX | XXX | XXX |
| P/E | -2.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -2.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpTaysha GTx's NTM/LTM revenue growth is -31%
Taysha GTx's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $1.3M for the same period.
Over next 12 months, Taysha GTx's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Taysha GTx's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Taysha GTx and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -46% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -1055% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -16% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -1087% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $1.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 347% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 792% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 1139% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Taysha GTx acquired XXX companies to date.
Last acquisition by Taysha GTx was XXXXXXXX, XXXXX XXXXX XXXXXX . Taysha GTx acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Taysha GTx founded? | Taysha GTx was founded in 2019. |
| Where is Taysha GTx headquartered? | Taysha GTx is headquartered in United States of America. |
| How many employees does Taysha GTx have? | As of today, Taysha GTx has 73 employees. |
| Who is the CEO of Taysha GTx? | Taysha GTx's CEO is Mr. Sean P. Nolan. |
| Is Taysha GTx publicy listed? | Yes, Taysha GTx is a public company listed on NAS. |
| What is the stock symbol of Taysha GTx? | Taysha GTx trades under TSHA ticker. |
| When did Taysha GTx go public? | Taysha GTx went public in 2020. |
| Who are competitors of Taysha GTx? | Similar companies to Taysha GTx include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Taysha GTx? | Taysha GTx's current market cap is $262M |
| What is the current revenue of Taysha GTx? | Taysha GTx's last 12-month revenue is $7.6M. |
| What is the current EBITDA of Taysha GTx? | Taysha GTx's last 12-month EBITDA is -$91.8M. |
| What is the current EV/Revenue multiple of Taysha GTx? | Current revenue multiple of Taysha GTx is 24.4x. |
| What is the current EV/EBITDA multiple of Taysha GTx? | Current EBITDA multiple of Taysha GTx is -2.0x. |
| What is the current revenue growth of Taysha GTx? | Taysha GTx revenue growth between 2023 and 2024 was -46%. |
| Is Taysha GTx profitable? | Yes, Taysha GTx is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
